FOLLICULAR DENDRITIC CELL SARCOMA

Clinical trials for FOLLICULAR DENDRITIC CELL SARCOMA explained in plain language.

Never miss a new study

Get alerted when new FOLLICULAR DENDRITIC CELL SARCOMA trials appear

Sign up with your email to follow new studies for FOLLICULAR DENDRITIC CELL SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Immune-Boosting drug tested for Tough-to-Treat rare cancers

Disease control Terminated

This study is testing a drug called pembrolizumab for people with rare, aggressive cancers of the immune system (like certain lymphomas and histiocyte/dendritic cell sarcomas) that have come back or not responded to standard treatments. The drug works by helping the body's own im…

Matched conditions: FOLLICULAR DENDRITIC CELL SARCOMA

Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control

Last updated Apr 04, 2026 05:06 UTC

FOLLICULAR DENDRITIC CELL SARCOMA

Get alerted when new FOLLICULAR DENDRITIC CELL SARCOMA trials appear

Immune-Boosting drug tested for Tough-to-Treat rare cancers